enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Luspatercept - Wikipedia

    en.wikipedia.org/wiki/Luspatercept

    Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. [ 5 ] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication .

  3. What is the Mayo Clinic Diet — and is it healthy? - AOL

    www.aol.com/lifestyle/mayo-clinic-diet-does...

    The Mayo Clinic Diet focuses on building new healthy habits and breaking old, less-healthy habits to help with weight loss and overall health.

  4. Everything you need to know about the Mayo Clinic diet - AOL

    www.aol.com/lifestyle/everything-know-mayo...

    The Mayo Clinic diet was created by weight management practitioners at the Mayo Clinic and was designed as a lifestyle change program to promote gradual and sustained weight loss, says Melissa ...

  5. Geron's blood disorder drug gets FDA advisers' backing - AOL

    www.aol.com/news/gerons-blood-disorder-drug-gets...

    Geron is seeking approval to use imetelstat for treating transfusion-dependent anemia in patients with a group of blood cancers called myelodysplastic syndromes (MDS).

  6. Myelodysplastic syndrome - Wikipedia

    en.wikipedia.org/wiki/Myelodysplastic_syndrome

    A myelodysplastic syndrome (MDS) is one of a group of cancers in which blood cells in the bone marrow do not mature, and as a result, do not develop into healthy blood cells. [3] Early on, no symptoms typically are seen. [3] Later, symptoms may include fatigue, shortness of breath, bleeding disorders, anemia, or frequent infections. [3]

  7. Mayo Clinic Diet - Wikipedia

    en.wikipedia.org/wiki/Mayo_Clinic_Diet

    The Mayo Clinic Diet is a diet book first published in 1949 by the Mayo Clinic's committee on dietetics as the Mayo Clinic Diet Manual. [1] Prior to this, use of the term "diet" was generally connected to fad diets with no association to the clinic.

  8. US FDA staff raises concerns on Geron's blood disorder drug - AOL

    www.aol.com/news/us-fda-staff-flags-concerns...

    Geron is seeking approval of the injectable drug, called imetelstat, for treating transfusion-dependent anemia in patients with a group of blood cancers called myelodysplastic syndromes (MDS).

  9. Promyelocyte - Wikipedia

    en.wikipedia.org/wiki/Promyelocyte

    Myelodysplastic Syndromes (MDS) are a group of disorders characterized by ineffective hematopoiesis or dysplasia changes in some myeloid lineages of the bone marrow. Abnormalities in promyelocyte maturation may contribute to pathogenesis of MDS and its associated complications. [ 6 ]